ArticleNPJ breast cancer2023

Inhibition of CXorf56 promotes PARP inhibitor-induced cytotoxicity in triple-negative breast cancer.

Ying Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.